Hypoxia and drug resistance

Cited by (564)

Items 301–400 of 564

1. Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts
   J Liu, Hiroshi Harada, Masakazu Ogura, Toru Shibata, Masahiro Hiraoka · 2007 · British Journal of Cancer
2. Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells
   Oleg V. Markov, Nadezhda L. Mironova, Valentin V. Vlassov, Зенкова Марина Аркадьевна · 2016 · Acta Naturae
3. Induction of cellular prion protein (PrPc) under hypoxia inhibits apoptosis caused by TRAIL treatment
   Jin‐Young Park, Jae‐Kyo Jeong, Ju‐Hee Lee, Ji-Hong Moon, Sung-Wook Kim, You-Jin Lee, Sang‐Youel Park · 2015 · Oncotarget
4. Biomolecular Markers in Cancer of the Tongue
   Daris Ferrari, Carla Codecà, Jessica Fiore, Laura Moneghini, Silvano Bòsari, Paolo Foa · 2009 · Journal of Oncology
5. A two-phase strategy for treatment of oxidant-dependent cancers
   Mark Frederick McCarty, Jorge Barroso-Aranda, Francisco Contreras · 2007 · Medical Hypotheses
6. Molecular markers in bladder cancer
   Syed A. Hussain, Nicholas David James · 2005 · Seminars in Radiation Oncology
7. A Key Pathway to Cancer Resilience: The Role of Autophagy in Glioblastomas
   Elisa Helena Farias Jandrey, Marcelle Bezerra, Lilian T. Inoue, Frank B. Furnari, Anamaria A. Camargo, Erico Tosoni Costa · 2021 · Frontiers in Oncology
8. Prognostic value of hypoxia‐associated markers in advanced larynx and hypopharynx squamous cell carcinoma
   Jonathan M. Bernstein, Timothy D. Andrews, Nick J. Slevin, Catharine West, Jarrod James Homer · 2014 · The Laryngoscope
9. Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation
   Ingrid Nyhus Moen, Charlotte Jevne, Jian Wang, Karl-Henning Kalland, Martha Chekenya, Lars A. Akslen, Linda Sleire, Per Øyvind Enger, Rolf Kåre Reed, Anne Margrete Oyan et al. · 2012 · BMC Cancer
10. Hypoxia-Regulated Expression of Attenuated Diphtheria Toxin A Fused with Hypoxia-Inducible Factor-1α Oxygen-Dependent Degradation Domain Preferentially Induces Apoptosis of Hypoxic Cells in Solid Tumor
    Nobuko Koshikawa, Keizo Takenaga · 2005 · Cancer Research
11. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells
    Sumaira Amir, Naira V. Margaryan, Valerie Odero-Marah, Zhila Khalkhali‐Ellis, Mary J.C. Hendrix · 2005 · Cancer Biology & Therapy
12. Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
    Baoan Chen, Ping Liu, Haijun Zhang, Xue Wu, Liting Guo, Fei Wang, Guohua Xia, Haixiang Yin, Yonglu Wang, Xueming Li · 2016 · OncoTargets and Therapy
13. Cytotoxic Ru II - p -cymene complexes of an anthraimidazoledione: halide dependent solution stability, reactivity and resistance to hypoxia deactivation
    Amrita Sarkar, Sourav Acharya, Kumar Khushvant, Kallol Purkait, Arindam Mukherjee · 2019 · Dalton Transactions
14. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion
    Martin Smollich, Martin Götte, Christian Kersting, J Fischgräbe, Ludwig Kiesel, Pia Wülfing · 2007 · Breast Cancer Research and Treatment
15. Exogenous and Endogenous Markers of Tumour Oxygenation Status
    Kaye Janine Williams, Catriona Anne Parker, Ian James Stratford · 2005 · Advances in experimental medicine and biology
16. p53 Checkpoint-Defective Cells Are Sensitive to X Rays, but Not Hypoxia
    Nicholas C. Denko, Susannah Green, Diana Edwards, Amato J. Giaccia · 2000 · Experimental Cell Research
17. Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro
    Rubi Skøyum, Kathleen Eide, Kristian Berg, EK Rofstad · 1997 · British Journal of Cancer
18. Synthesis of ‘dual-key-and-lock’ drug carriers for imaging and improved drug release
    Haiqing Gao, Yongqi Zhang, Bin Chi, Caixue Lin, Feng Tian, Mingyue Xu, Yingxi Wang, Zushun Xu, Ling Li, Jing Wang · 2020 · Nanotechnology
19. Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs
    Wan-Lin Liao, Shao-Chieh Lin, H. Sunny Sun, Shaw‐Jenq Tsai · 2014 · Biomarkers and Genomic Medicine
20. Nitric Oxide Donors Are a New Class of Anti-cancer Therapeutics for the Reversal of Resistance and Inhibition of Metastasis
    Benjamin Bonavida, Stavroula Baritaki, Sara Huerta‐Yépez, Mario I. Vega, Ali R. Jazirehi, James R. Berenson · 2010 · Springer eBooks
21. In Vitro Testing of Chemosensitivity in Physiological Hypoxia
    Rita S. Grigoryan, Nino Keshelava, Clarke Anderson, C. Patrick Reynolds · 2005 · Humana Press eBooks
22. THEORETICAL STUDY OF ADIABATIC AND VERTICAL ELECTRON AFFINITY OF RADIOSENSITIZERS IN SOLUTION PART 2: ANALOGUES OF TIRAPAZAMINE
    Teodorico C. Ramalho, Elaine F. F. da Cunha, Ricardo Bicca de Alencastro · 2004 · Journal of Theoretical and Computational Chemistry
23. The Prognostic Value of Anaemia at Different Treatment Times in Patients with Locally Advanced Head and Neck Cancer Treated with Surgery and Postoperative Radiotherapy
    B. Dietl, Jörg Marienhagen, Christof Schäfer, Oliver Kölbl · 2007 · Clinical Oncology
24. Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model
    Xiao-Bing Liu, Qiao Cheng, Wei Geng, Chang-Chun Ling, Yan Liu, TP Ng, Judy Wai Ping Yam, Xin‐Yuan Guan, Chung Mau Lo, Kwan Man · 2013 · Artificial Cells Nanomedicine and Biotechnology
25. Applications of Positron Emission Tomography in the Development of Molecular Targeted Cancer Therapeutics
    Benjamin Solomon, Grant A. McArthur, Carleen M. Cullinane, John Raymond Zalcberg, Rodney J. Hicks · 2003 · BioDrugs
26. Tirapazamine Administered as a Neoadjuvant to Radiotherapy Reduces Metastatic Dissemination
    Sarah Jane Lunt, Brian A. Telfer, Richard J. Fitzmaurice, Ian James Stratford, Kaye Janine Williams · 2005 · Clinical Cancer Research
27. FDG-PET in Monitoring Therapy of Breast Cancer
    Hans‐Jürgen Biersack, Hans Bender, HOLGER PALMEDO · 2007 · Springer eBooks
28. Hypoxia and angiogenesis in experimental tumor models: Therapeutic implications
    Sara Rockwell, Jonathan P.S. Knisely · 1997 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
29. Correction of Cancer Anemia – Impact on Disease Course, Prognosis and Treatment Efficacy, Particularly for Patients Undergoing Radiotherapy
    Michael Henke · 2001 · Oncology Research and Treatment
30. Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
    Jiarui Zhang, Zhang Jinan, Yang Chen · 2025 · Journal of Translational Medicine
31. An oxygen-carrying and lysosome-targeting BODIPY derivative for NIR bioimaging and enhanced multimodal therapy against hypoxic tumors
    Jie Gao, Tianjiao Luan, Jiajia Lv, Mingyan Yang, Hongyu Li, Zeli Yuan · 2023 · Journal of Photochemistry and Photobiology B Biology
32. Experimental hypoxia is a potent stimulus for radiotracer uptake in vitro: Comparison of different tumor cells and primary endothelial cells
    Joachim Oswald, Franziska Treite, Cathleen Haase‐Kohn, Thomas Kampfrath, Peter Mäding, Bernd Schwenzer, Ralf Bergmann, Jens Pietzsch · 2007 · Cancer Letters
33. Highly stable and biocompatible W 18 O 49 @PEG-PCL hybrid nanospheres combining CT imaging and cancer photothermal therapy
    Jianning Mu, Xiaoyu Meng, Li Chen, Zhanbin Lu, Qinwei Mou, Xiaoxue Li, Suiqin Wang, Hongyun Yue · 2017 · RSC Advances
34. Hypoxic cytotoxic agents: a new approach to cancer chemotherapy
    J. Martin Brown · 2000 · Drug Resistance Updates
35. Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma
    Henk J. Broxterman, N H Georgopapadakou · 2007 · Drug Resistance Updates
36. Arsenic trioxide and neuroblastoma cytotoxicity
    Helen M. Pettersson, Jenny Karlsson, Alexander Pietras, Ingrid Øra, Sven Påhlman · 2007 · Journal of Bioenergetics and Biomembranes
37. Efficacy of Pentavalent Antimony, Amphotericin B, and Miltefosine in Leishmania amazonensis-Infected Macrophages Under Normoxic and Hypoxic Conditions
    Diana Copi Ayres, L. A. Pinto, Selma Giorgio · 2008 · Journal of Parasitology
38. Impact Of Hypoxic And Acidic Extracellular Conditions On Cytotoxicity Of Chemotherapeutic Drugs
    Oliver Thews, Birgit Gaßner, Debra K. Kelleher, Gerald Schwerdt, Michael Gekle · 2007 · Springer eBooks
39. Mathematical modeling of chronical hypoxia in tumors considering potential doubling time and hypoxic cell lifetime
    Kårstein Måseide, Einar K. Rofstad · 2000 · Radiotherapy and Oncology
40. Inorganic Compounds of Carbon, Nitrogen, and Oxygen
    George D. Leikauf, Daniel R. Prows · 2012 · Patty's Toxicology
41. Long-term observation reveals time-course-dependent characteristics of tumour vascularisation
    Nils Hansen‐Algenstaedt, Claudia Joscheck, Christian Schaefer, Katrin Lamszus, Lars Wolfram, Tanja Biermann, Petra Algenstaedt, Marc Alexander Brockmann, Carsten Heintz, Walter Fiedler et al. · 2005 · European Journal of Cancer
42. Carbogen Breathing Differentially Enhances Blood Plasma Volume and 5-Fluorouracil Uptake in Two Murine Colon Tumor Models with a Distinct Vascular Structure
    Hanneke W.M. van Laarhoven, Giulio Gambarota, Jasper Lok, Martin M. Y. Lammens, Yvonne J. L. Kamm, Theo Wagener, Cornelis J.A. Punt, Albert J. van der Kogel, Arend Heerschap · 2006 · Neoplasia
43. Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells
    Jeng-Ting Chen, Chien-Chun Liu, Jau‐Song Yu, Hung‐Hsuan Li, Ming‐Chih Lai · 2018 · Journal of Proteomics
44. Dual “Unlocking” Strategy to Overcome Inefficient Nanomedicine Delivery and Tumor Hypoxia for Enhanced Photodynamic‐Immunotherapy
    Xianglong Li, Cong Jiang, Xinlin Jia, Yuanyuan Cao, Yuanqing Mao, Ji‐Na Hao, Yang Yang, Peng Zhang, Yongsheng Li · 2022 · Advanced Healthcare Materials
45. Angiogenic Effects of Erythropoietin
    Doménico Ribatti · 2012 · International review of cytology
46. Synthesis and evaluation of nitro 5-deazaflavin-pyrrolecarboxamide(s) hybrid molecules as novel DNA targeted bioreductive antitumor agents
    Yoshitomo Kanaoka, Yoshihiro Ikeuchi, Tetsuji Kawamoto, Kiyoshi Bessho, Naoshige Akimoto, Yuji Mikata, Mamiko Nishida, Shigenobu Yano, Takuma Sasaki, Fumio Yoneda · 1998 · Bioorganic & Medicinal Chemistry
47. Use of ozonated water as a new therapeutic approach to solve current concerns around antitumor treatment
    Kohei Kuroda, Masamiti Yamashita, Yusuke Murahata, Kazuo Azuma, Tomohiro Osaki, Takeshi Tsuka, Norihiko Ito, Tomohiro Imagawa, Yoshiharu Okamoto · 2018 · Experimental and Therapeutic Medicine
48. Aqua-(2-formylbenzoato)triphenyltin(IV) induces cell cycle arrest and apoptosis in hypoxic triple negative breast cancer cells
    Virendra Singh, Nishant Kumar Rana, Mohammad Kashif, Partha Pratim Manna, Tushar S. Basu Baul, Biplob Koch · 2022 · Toxicology in Vitro
49. Impact of Hypoxia-Related Tumor Acidosis on Cytotoxicity of Different Chemotherapeutic Drugs In Vitro and In Vivo
    Oliver Thews, Anne Riemann, Martin Nowak, Michael Gekle · 2014 · Advances in experimental medicine and biology
50. A microfluidic chip of multiple-channel array with various oxygen tensions for drug screening
    Yaqiong Li, Lili Li, Zhengxiao Liu, Mingyu Ding, Guoan Luo, Qionglin Liang · 2016 · Microfluidics and Nanofluidics
51. Liposome-Encapsulated Hemoglobin Enhances Chemotherapy to Suppress Metastasis in Mice
    Chieko Murayama, Akira T. Kawaguchi, Akemi Kamijo, Katsuko Naito, Kayoko Iwao, Hideo Tsukamoto, Kayo Yasuda, Yasukazu Nagato · 2014 · Artificial Organs
52. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells
    Akansha Jalota, Mukesh Kumar, Bhudev Chandra Das, Ajay K. Yadav, Kunzang Chosdol, Subrata Sinha · 2018 · Oncotarget
53. Cytotoxicity analysis of etoposide and cisplatin on cell lines from human lung cancer and normal human lung
    GI Davou, Chuwang J. Nyam, UC Essien, TPP Choji, BC Echeonwu, Lugos · 2019 · International Research Journal of medicine and Medical Sciences
54. Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cells
    James Forde, Antoinette Sabrina Perry, Kevin Brennan, Lynn M. Martin, Mark Lawler, Thomas Hugh Lynch, Donal P. Hollywood, Laure H. Marignol · 2010 · Urologic Oncology Seminars and Original Investigations
55. Positron emission tomography to assess hypoxia and perfusion in lung cancer
    Eline E. Verwer · 2014 · World Journal of Clinical Oncology
56. Downregulation of hexokinase 2 improves radiosensitivity of breast cancer
    Dan Zhang, Hui Wang, Wenjing Yu, Feng Qiao, Xiaoyu Su, Huiqin Xu · 2019 · Translational Cancer Research
57. Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia
    Jenny Karlsson, Anders Edsjö, Sven Påhlman, Helen M. Pettersson · 2005 · Molecular Cancer Therapeutics
58. Synthesis and evaluation of nitro 5-deazaflavins as novel bioreductive antitumor agents
    Tetsuji Kawamoto, Yoshihiro Ikeuchi, Junko Hiraki, Yoshiteru Eikyu, Kazue Shimizu, Masaki Tomishima, Kiyoshi Bessho, Fumio Yoneda, Yuji Mikata, Mamiko Nishida et al. · 1995 · Bioorganic & Medicinal Chemistry Letters
59. Hypoxia in tumors: molecular targets for anti-cancer therapeutics
    Kaye Janine Williams, Rachel L. Cowen, Louisa M. Brown, Edwin C. Chinje, Mohammed Jaffar, Ian James Stratford · 2004 · Advances in Enzyme Regulation
60. Self-reporting hypoxia-responsive supramolecular phototheranostic nanomaterials based on AIEgen and azocalixarene
    Xiao-Wen Han, Guo-Ling Zhang, Pu Chen, Jing Zhang, Guo‐Gang Shan, Chunxuan Qi, Ben Zhong Tang, Hai‐Tao Feng · 2025 · Science China Chemistry
61. Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line
    Ling Fu, Yin Fen, Xiaorui Li, Bing‐Kai Han, Chuang Zhang, Jun-Wei Wang, Yuqing Wang, Yuefeng Bi, Hong‐Min Liu · 2018 · Anti-Cancer Drugs
62. Targeting Glioma Stem Cells
    Yagmur Muftuoglu, Frank Pajonk · 2021 · Neurosurgery Clinics of North America
63. The prognostic role of pre-chemotherapy hemoglobin level in patients with ovarian cancer
    Massimo Di Maïo · 2006 · Frontiers in bioscience
64. A new generation of MDR modulating agents with dual activity: P-gp inhibitor and iNOS inducer agents
    Nicola Antonio Colabufo, Marialessandra Contino, Francesco Berardi, Roberto Perrone, Maria Antonietta Panaro, Antonia Cianciulli, Vincenzo Mitolo, Amalia Azzariti, Annelisa Quatrale, Angelo Paradiso · 2010 · Toxicology in Vitro
65. Molecular oxygen loading in candidate theranostic droplets stabilized with biocompatible fluorinated surfactants: Particle size effect and application to in situ 19F MRI mapping of oxygen partial pressure
    Orane Lorton, Jean‐Noël Hyacinthe, Stéphane Desgranges, Laura Gui, Antoine Klauser, Zarko Celicanin, Lindsey Alexandra Crowe, François Lazeyras, Éric Allémann, Nicolas Taulier et al. · 2018 · Journal of Magnetic Resonance
66. Factors Involved in the Design of Cytotoxic Payloads for Antibody–Drug Conjugates
    Wayne C. Widdison, Ravi V. J. Chari · 2012 · Springer eBooks
67. Ovarian Cancer: Can We Reverse Drug Resistance?
    David S.P. Tan, Joo Ern Ang, Stan B. Kaye · 2008 · Springer eBooks
68. Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery
    Alexander McDermott, Ali Tavassoli · 2024 · Transcription
69. Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy
    Lina Alhalhooly, Babak Mamnoon, Jiha Kim, Sanku Mallik, Yongki Choi · 2021 · Oncotarget
70. Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LHBETATAG retinoblastoma tumors
    Timothy G. Murray, Samuel K Steven Houston, Yolanda Piña, Timothy G. Murray, H. Boutrid, Colleen M. Cebulla, Amy C Schefler, Wei Shi, Magda Celdran, William J. Feuer et al. · 2011 · Clinical ophthalmology
71. Hypoxia aggravates the burden of yellowstripe goby (Mugilogobius chulae) under atorvastatin exposure
    Yimeng Wang, Tianli Tang, Jinzhi Ren, Yufei Zhao, Yingshi Hou, Xiangping Nie · 2022 · Aquatic Toxicology
72. Raman spectroscopy and SERS analysis of ovarian tumour derived exosomes (TEXs): a preliminary study
    Laura T. Kerr, Luke Gubbins, Karolina Weiner‐Gorzel, Shiva Sharma, Malcolm Kell, Amanda H McCann, Bryan M. Hennelly · 2014 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
73. Topology and dynamics of the interaction between 5-nitroimidazole radiosensitizers and duplex DNA studied by a combination of docking, molecular dynamic simulations and NMR spectroscopy
    Teodorico C. Ramalho, Tanos C. C. França, Wilian Augusto Cortopassi, Arlan da Silva Gonçalves, Alan Sousa da Silva, Elaine F. F. da Cunha · 2011 · Journal of Molecular Structure
74. Differential Radiosensitivity of Uveal Melanoma Cell Lines After X-rays or Carbon Ions Radiation
    Armelle Calipel, Anne‐Laure Lux, Sylvain L. Guérin, Jean-Louis Lefaix, Carine Laurent, Myriam Bernaudin, F. Mouriaux · 2015 · Investigative Ophthalmology & Visual Science
75. Implications of Oxygen Homeostasis for Tumor Biology and Treatment
    Boyan K. Garvalov, Till Acker · 2016 · Advances in experimental medicine and biology
76. A Clinical Study of Hypoxia Using Endogenous Hypoxic Markers and Polarographic Oxygen Electrodes
    Koh‐ichi Sakata, Masanori Someya, Hisayasu Nagakura, Kensei Nakata, Atushi Oouchi, Masato Hareyama, Masaaki Satoh · 2006 · Strahlentherapie und Onkologie
77. Atrial Natriuretic Peptide Attenuates Hypoxia Induced Chemoresistance in Prostate Cancer Cells
    Erin N. Bell, Man Yat Tse, Lisa J. Frederiksen, Amanda Gardhouse, Stephen Ching-ng Pang, Charles H. Graham, David Robert Siemens · 2007 · The Journal of Urology
78. Tumor hypoxia and therapeutic resistance
    Peter W. Vaupel, Michael Höckel · 2008 · Springer eBooks
79. Target molecular therapies: methods to enhance and monitor tumor drug delivery
    Benjamin L. Viglianti · 2008 · Abdominal Imaging
80. Expression of N-WASP is regulated by HiF1α through the hypoxia response element in the N-WASP promoter
    Amrita Salvi, Thirumaran Thanabalu · 2016 · Biochemistry and Biophysics Reports
81. Tirapazamine with Cisplatin and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study
    Michel Gatineau, Olivier Rixe, Thierry Le Chevalier · 2005 · Clinical Lung Cancer
82. Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?
    Edwin C. Chinje, Adam Vorn Patterson, Mark P. Saunders, Stacey D. Lockyer, Adrian Llewellyn Harris, Ian James Stratford · 1999 · British Journal of Cancer
83. Safety and efficacy of high‐dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas
    Benjamin Chen, Tauseef Ahmed, Anney Mannancheril, Michael L. Gruber, Deborah L. Benzil · 2004 · Cancer
84. Erythropoietin enhances response to treatment in patients with advanced breast cancer
    Anna-Maria Larsson, Göran Landberg, Sven Påhlman, Maria Albertsson · 2004 · Acta Oncologica
85. Photodynamic Therapy-Accelerated Hypoxia-Responsive Prodrug Release for Synergistic Photo-Chemotherapy of Melanoma Cancer Based on Noncovalent Interactions
    Jing Zhang, Xiao-Wen Han, Pu Chen, Guo‐Gang Shan, Guorui Jin, Hai‐Tao Feng, Ben Zhong Tang · 2025 · ACS Materials Letters
86. Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines
    Manabu Okajima, Satoshi Kokura, Takeshi Ishikawa, Katsura Mizushima, Reiko Tsuchiya, Tatsuzo Matsuyama, Satoko Adachi, Tetsuya Okayama, Naoyuki Sakamoto, Kazuhiro Kamada et al. · 2013 · Oncology Reports
87. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression
    Samira Naderinezhad, Guoliang Zhang, Zheng Wang, Dayong Zheng, Mohit M. Hulsurkar, Michael Bakhoum, Ning Su, Han Yang, Tao Shen, Wenliang Li · 2023 · Cancer Letters
88. Imatinib increases oxygen delivery in extracellular matrix-rich but not in matrix-poor experimental carcinoma
    Mikhail Burmakin, Tijs van Wieringen, P. Olof Olsson, Linda E. B. Stuhr, Aive Åhgren, Carl‐Henrik Heldin, Rolf Kåre Reed, Kristofer Rubin, Carina B. Hellberg · 2017 · Journal of Translational Medicine
89. Ultrasound mediated delivery of oxygen and LLL12 loaded stimuli responsive microdroplets for the treatment of hypoxic cancer cells
    Jinshun Xu, Shuai Yuan, Jilai Tian, Kyle A. Martin, Jinhua Song, Chenglong Li, Zhigang Wang, Jiayuh Lin, Ting Si, Ronald X. Xu · 2017 · Scientific Reports
90. Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome
    Gabriella Ferrandina, Mariagrazia Distefano, Daniela Smaniotto, ALESSIO GIUSEPPE MORGANTI, Amelia Paglia, Gabriella Macchia, Barbara Corvari, Domenica Lorusso, Giovanni Scambia · 2006 · Gynecologic Oncology
91. Epigenetic therapies - a new direction in clinical medicine
    Richard Albert Stein · 2014 · International Journal of Clinical Practice
92. Effects of fluctuating oxygenation on tirapazamine efficacy: Theoretical predictions
    Laura I. Cárdenas-Navia, Timothy W. Secomb, Mark W. Dewhirst · 2007 · International Journal of Radiation Oncology*Biology*Physics
93. Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
    Yongqing Cai, Jian Huang, Haiyan Xing, Bin Li, Ling Li, Xianfeng Wang, Dan Peng, Jianhong Chen · 2018 · OncoTargets and Therapy
94. COMPUTATIONAL NMR INVESTIGATION OF RADIOSENSITIZER IN SOLUTION
    Teodorico C. Ramalho, Elaine F. F. da Cunha, Fernando Cunha Peixoto, José Daniel Figueroa‐Villar · 2008 · Journal of Theoretical and Computational Chemistry
95. Improved radiosensitizing effect of the combination of etanidazole and paclitaxel for hepatocellular carcinoma in vivo
    Yanling Yang, Cheng S. Jin, Haimin Li, Yong He, ZHAOHUI LIU, Ling Bai, KEFENG DOU · 2011 · Experimental and Therapeutic Medicine
96. Tumors may modulate host immunity partly through hypoxia-induced sympathetic bias
    Anthony J. Yun, Kimberly A. Bazar, Patrick Y. Lee · 2004 · Medical Hypotheses
97. Co-expression of HIF-1α, MDR1 and LAPTM4B in peripheral blood of solid tumors
    Zaira Rehman, Ammad Fahim, Attya Bhatti, Hajra Sadia, Peter C. L. John · 2019 · PeerJ
98. Hypoxia Activated Prodrugs of a 9-Aza-anthrapyrazole Derivative That Has Promising Anticancer Activity
    Mohammad H. El‐Dakdouki, Nicholas L. Adamski, Lecia Foster, Miles P. Hacker, Paul Erhardt · 2011 · Journal of Medicinal Chemistry
99. The cellular adaptations to hypoxia as novel therapeutic targets in childhood cancer
    Jennifer Adamski, EJ Estlin, Guy Makin · 2008 · Cancer Treatment Reviews
100. Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points
     EK Rofstad, Kårstein Måseide · 1998 · British Journal of Cancer